Under the 1974 'Bilateral Protocol on Visits to Religious Shrines' between India and Pakistan, there are four occasions every year on which...

We plan to continue this strategy during the coming low-demand seasons as well to avoid losses,“ said D Ram Reddy, managing director at Sne...

Poultry farmers in Telangana, Andhra Pradesh and Tamil Nadu are an enraged lot after the external affairs ministry's proposal to allow duty...

With Jaganmohan Reddy completing a year in jail, his wife Bharathi today attacked CBI, alleging it was controlled by partisan interests.

Party also sought a clarification from the PM, charging the government with trying to influence the working of the premier investigation.

The US Food and Drug Administration has allowed Ranbaxy to manufacture generic Lipitor at Ohm Labs facility in the US for American market.

SC has rejected the Gujarat government's unilateral decision to appoint a new chairperson of the committee to monitor investigations into 2...

Dr Reddy’s Laboratories’ revenues in the December quarter jumped to Rs 2,770 crore, buoyed by the launch of a star performing drug and a we...

Dr Reddy's Laboratories (DRL) has split a key marketing division into two parts in a bid to resurrect its ailing domestic business.

Indian drugmakers posted 21% month-on-month growth in November sales, which was the highest in the past 14 months

Pfizer's Lipitor is the world's largest-selling drug, which generated about $7 billion in sales last year in the US alone.

Growth plans force pharma companies to hunt for talent. Expansion planned in small towns and rural areas.

The state government, which sought the continuation of the stay on mining activity at Obalapuram mines, said that iron ore was being illega...

Most MNCs are focusing on India and emerging markets to sustain their growth as the US and Europe markets slow down.

Dr Reddy's Laboratory, which defeated Ranbaxy in acquiring German company Betapharm, today said the Ranbaxy-Daiichi deal is "path breaking".

Investors are gearing up for a bitter pill from the pharma industry, as the third quarter ended December was marked by ever-rising competit...

They work hard, they party harder. The ET Awards give Corporate India a chance to let its hair down, live it up and not pull any punchlines.